Nos actualités et évènements
Efficience des équipes et des organisations, la clé de croissance pour votre entreprise !
Efficience ou Efficacité : Serait-ce uniquement une question de sémantique ? L’Efficacité : Remplir le contrat, satisfaire le client, atteindre l’objectif. L’Efficacité ne préjuge en rien de l’ensemble des ressources mobilisées pour obtenir ce résultat. L’Efficience : Mesurer [...]
Pour aller plus loin …
- LivaNova to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Monday, November 23rd 2020 at 2:00pm UTC LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien...Rédaction
- Celltrion termine le recrutement de l’essai clinique mondial de Phase II évaluant le traitement candidat CT-P59 contre la COVID-19 Friday, November 27th 2020 at 1:32am UTC Celltrion annonce le recrutement de 327 patients COVID-19 pour l’essai clinique mondial de...Rédaction
- Alzprotect Strengthens Its Intellectual Property Portfolio for Its First-in-Class Clinical Stage Drug Ezeprogind Monday, November 23rd 2020 at 10:33am UTC LILLE, France–(BUSINESS WIRE)– Alzprotect, a biopharmaceutical company developing therapeutic solutions for neurodegenerative diseases...Rédaction
- Rural Clinical and Healthcare Logistics Market 2020-2024: Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, Covid-19 Impact Analysis, Forecast to 2024 | Technavio Friday, November 27th 2020 at 2:17pm UTC LONDON–(BUSINESS WIRE)– The new rural clinical and healthcare logistics market research from Technavio...Rédaction
- Exactech and Bodycad Sign Exclusive Distribution Agreement to Offer Personalized Unicompartmental Knee Replacement Tuesday, November 24th 2020 at 2:30pm UTC Partnership Expands Exactech’s Active Intelligence® Portfolio of Smart Solutions GAINESVILLE, Fla. & QUEBEC...Rédaction
- ImmunityBio Announces Publication of Preclinical Data Demonstrating IL-15 Superagonist N-803 Improves Natural Killer-Mediated Tumor Cell Killing Monday, November 23rd 2020 at 2:00pm UTC N-803 Boosts CD34+ Progenitor-Derived NK Cell Expansion and Functionality Adding N-803 to NK...Rédaction
- Greenwich LifeSciences Announces Second Publication and Second Poster Presentation of Phase III Clinical Trial of Potential Breakthrough Technology for Recurring Breast Cancer Monday, November 23rd 2020 at 12:00pm UTC ‒ Phase III clinical trial to be led by Baylor College of Medicine...Rédaction
- Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3 Friday, November 27th 2020 at 3:39pm UTC STONY BROOK, N.Y.–(BUSINESS WIRE)– Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or...Rédaction
- FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics using novel discovery platforms Monday, November 23rd 2020 at 10:10am UTC Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be...Rédaction
- Legend Biotech Announces New Appointment to the Board of Directors and Resignation of Dr. Fangliang Zhang Monday, November 23rd 2020 at 12:00pm UTC SOMERSET, N.J.–(BUSINESS WIRE)– Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage...Rédaction